Swiss Healthcare Start-ups (SHS) nominated Dr. H. Flaadt (Founder & Director, Center of Advanced Studies on Entrepreneurship in BioMedicine) as a new member of the advisory board. SHS is a non-profit organization in Zurich helping accelerate healthcare startups.
We wish Mathew Farkash, founder of Blueprint Health (NY), an early-stage healthcare investment firm and visiting faculty on Bio- and eHealth Entrepreneurship at CASE BioMed, as well as his newly wedded wife all the best, happiness and love on their journey through life together.
The first edition of the accompanying book to the Bio- and MedTech Business programs (eds. Heidrun Flaadt & Jörg Dogwiler) is sold at half price. The book differs from the second edition only in a chapter on Medical Device Regulation (MedTech).
Cellerys, co-founded by BioBusiness2014 alumnus Prof. A. Lutterotti, develops a therapy to combat multiple sclerosis. Novartis has signed a collaboration agreement and an option to acquire Cellerys, a spin-off from the University of Zurich, upon completion of Phase 2.
Dr. Philipp Knechtle, CSO, discoveric bioEach start-up entrepreneur in the life science area should profit from this unique opportunity. This high quality program fosters the life science start-up scene in Switzerland.
